Ikarian Capital, LLC Athenex, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $32,815 - $72,835	-80,039 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.79 - $1.59 $3,081 - $6,201	3,900 Added 5.12%	80,039 $68,000
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $367,867 - $599,487	-123,861 Reduced 61.93%	76,139 $228,000
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $742,000 - $1.03 Million	200,000 New	200,000 $923,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.